Novartis AG

(NYSE:NVS)

Latest On Novartis AG (NVS):

Date/Time Type Description Signal Details
2024-03-07 04:57 ESTDividendA dividend of $3.78 has been announced on Feb 12, 2024. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 7, 2024.Neutral
2023-05-27 22:22 ESTNewsWhy 2023 is turning into the year of the healthcare spinoffN/A
2023-05-26 18:42 ESTNewsEMA recommends revoking approval of Novartis' sickle cell disease drug Adakveo in EUN/A
2023-05-25 14:01 ESTNewsNovartis' Sandoz gets EMA review for biosimilar to Amgen's Prolia, XgevaN/A
2023-05-22 14:42 ESTNewsAvrobio up 69% on plans to sell gene therapy program to NovartisN/A
2023-05-15 16:58 ESTNewsNovartis appoints 10-member board for Sandoz unit ahead of spinoffN/A
2023-05-10 09:08 ESTNewsNovartis' Sandoz to use Evotec's technology in pact to develop biosimilarsN/A
2023-05-04 05:49 ESTNewsNovartis' Sandoz inks pact to exclusively sell 6 products in USN/A
2023-05-03 17:23 ESTNewsImmix stock slumps ~20% amid interim data for IMX-110 in colorectal cancerN/A
2023-04-27 12:03 ESTNewsNovartis Cosentyx gets EMA panel backing to treat painful skin disorderN/A
2023-04-26 23:42 ESTNewsNovartis: Valuation Seems FairN/A
2023-04-26 11:33 ESTNewsBristol Myers to acquire viral vector manufacturing site in Illinois from NovartisN/A
2023-04-26 11:33 ESTNewsNovartis' iptacopan improves hemoglobin levels in rare blood disorder trial full dataN/A
2023-04-25 23:21 ESTNewsHot Stocks: Earnings sparked movement in PEP, JBLU, NVS, MCD, BIIB and HALN/A
2023-04-25 11:18 ESTNewsNovartis beats Q1 top and bottom line estimates; raises FY23 outlook & planned spin-off on track for H2N/A
2023-04-25 11:18 ESTNewsNovartis trades higher as Entresto, new drugs drive Q1 revenue, raises FY23 outlookN/A
2023-04-25 11:18 ESTNewsNovartis AG 2023 Q1 - Results - Earnings Call PresentationN/A
2023-04-25 11:18 ESTNewsNovartis: Limited Upside Despite Strong First Quarter Results, Improved GuidanceN/A
2023-04-25 11:17 ESTNewsNovartis AG (NVS) Q1 2023 Earnings Call TranscriptN/A
2023-04-24 23:47 ESTNewsNovartis hits 52-week high as Wall Street awaits Q1 2023 earningsN/A
2023-04-20 15:27 ESTNewsNovartis Kesimpta shows benefit in multiple sclerosis patients in 5-year dataN/A
2023-04-20 15:26 ESTNewsNovartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trialN/A
2023-04-19 16:50 ESTNewsAmgen wins appeals court ruling in patent dispute over psoriasis drug OtezlaN/A
2023-04-04 05:38 ESTNewsNovartis Humira biosimilar's high concentration gets approval in EUN/A
2023-03-31 12:40 ESTNewsNovartis' heart drug Entresto gets EMA nod for expanded use in childrenN/A
2023-03-28 14:10 ESTNewsBicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfrontN/A
2023-03-27 22:52 ESTNewsHot Stocks: ROKU and PINS rises on analyst upgrade; CAT stock and FYBR falls on downgrade; NVS higher on cancer trial successN/A
2023-03-27 22:52 ESTNewsNovartis upgraded to hold at Deutsche Bank following breast cancer drug resultsN/A
2023-03-27 22:51 ESTNewsWhy did Novartis stock go up today? Early breast cancer trial resultsN/A
2023-03-27 07:22 ESTNewsNovartis stock jumps on cancer trial successN/A
2023-03-22 19:34 ESTNewsNovartis Humira biosimilar's high concentration gets FDA approvalN/A
2023-03-22 19:34 ESTNewsNovartis to not go ahead with UK trial of cholesterol therapy Leqvio - reportN/A
2023-03-18 07:31 ESTNewsSangamo down post-market as Novartis, Biogen end collaborationsN/A
2023-03-17 16:30 ESTNewsNovartis Tafinlar Mekinist combo gets FDA approval to treat brain cancer in childrenN/A
2023-03-14 12:27 ESTNewsNovartis begins sale of certain eye care assets - reportN/A
2023-03-13 05:53 ESTNewsNovartis launches CHF10B stock buyback programN/A
2023-03-10 15:52 ESTNewsNovartis' Sandoz to invest $400M to build biosimilar production plant in SloveniaN/A
2023-03-09 04:56 ESTDividendA dividend of $3.47 has been announced on Feb 2, 2023. It will be paid Mar 20, 2023 with an ex-dividend date of Mar 9, 2023.Neutral
2023-03-06 21:20 ESTNewsVoyager stock pops on getting $25M from Novartis under license dealN/A
2023-03-06 21:19 ESTNewsNovartis: Cautiously Optimistic, HoldN/A
2023-03-03 14:06 ESTNewsNovartis files for FDA approval of radioligand facility to ramp up production of PluvictoN/A
2023-02-25 00:14 ESTNewsNovartis ends NASH collaboration with PliantN/A
2023-02-23 21:35 ESTNewsIntellia, Novartis end gene editing partnership for sickle cell diseaseN/A
2023-02-20 15:29 ESTNewsNovartis appoints perfume company Firmenich CEO as chairman-designate of SandozN/A
2023-02-09 03:55 ESTNewsNovartis CEO to lead top U.S. pharma lobbyN/A
2023-02-08 14:42 ESTNewsNovartis, Bayer commit financial aid to quake hit Turkey, Syria as rescue operations continueN/A
2023-02-07 12:29 ESTNewsNovartis' biosimilar of Amgen's bone disorder drugs Prolia, Xgeva gets FDA reviewN/A
2023-02-03 01:25 ESTNewsNovartis drops plans to develop Huntington’s disease candidateN/A
2023-02-01 23:01 ESTNewsNovartis ends plans to develop Cosentyx for another autoimmune conditionN/A
2023-02-01 10:00 ESTNewsNovartis reports mixed Q4 earnings, continue to grow with further core margin expansion; initiates FY23 guidanceN/A

About Novartis AG (NVS):

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

NVS Quotes by TradingView

See Advanced Chart

General

  • Name Novartis AG
  • Symbol NVS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 105,794
  • Last Split Factor1116:1000
  • Last Split Date2019-04-09
  • Fiscal Year EndDecember
  • IPO Date1991-11-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.novartis.com
View More

Valuation

  • Trailing PE 24.24
  • Forward PE 13.44
  • Price/Sales (Trailing 12 Mt.) 3.9
  • Price/Book (Most Recent Quarter) 3.38
  • Enterprise Value Revenue 4.35
  • Enterprise Value EBITDA 12.6
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $6.37
  • Next Year EPS Estimate $6.79
  • Next Quarter EPS Estimate $1.58
  • Profit Margin 16%
  • Operating Margin 24%
  • Return on Assets 6%
  • Return on Equity 14%
  • Revenue 49.76 billion
  • Earnings Per Share $3.52
  • Revenue Per Share $21.85
  • Gross Profit 35.36 billion
  • Quarterly Earnings Growth 1.9%
View More

Highlights

  • Market Capitalization 192.55 billion
  • EBITDA 17.27 billion
  • PE Ratio 13.98
  • PEG Ratio 2.19
  • Analyst Target Price $104.67
  • Book Value Per Share $25.08
View More

Share Statistics

  • Shares Outstanding 2.26 billion
  • Shares Float 2.11 billion
  • % Held by Insiders <1%
  • % Held by Institutions 10.08%
  • Shares Short 6.7 million
  • Shares Short Prior Month 5.35 million
  • Short Ratio 2.94
View More

Technicals

  • Beta 0.48
  • 52 Week High $94.72
  • 52 Week Low $67.52
  • 50 Day Moving Average 88.18
  • 200 Day Moving Average 88.65
View More

Dividends

  • Forward Annual Dividend Rate $3.2
  • Forward Annual Dividend Yield 3.74%
  • Payout Ratio 58%
  • Dividend Date 2021-03-15
  • ExDividend Date 2021-03-04
  • Dividend Per Share $3.4
  • Dividend Yield 3.84%
View More

Novartis AG (NVS) Dividend Calendar:

Novartis AG pays an annual dividend of $3.2 per share, with a dividend yield of 3.84%.
NVS's last dividend payment was made to shareholders on March 15, 2021.
Novartis AG pays out 58% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Novartis AG (NVS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-01-26$13.03 billion$1.34$1.39-3.81%
2020-09-302020-10-27$12.54 billion$1.52$1.454.88%
2020-06-302020-07-21$11.62 billion$1.36$1.332.07%
2020-03-312020-04-28$12.71 billion$1.56$1.3615.02%
2019-12-312020-01-29$12.72 billion$1.32$1.311.01%
2019-09-302019-10-22$12.48 billion$1.41$1.354.61%
2019-06-302019-07-18$12.02 billion$1.34$1.248.5%
2019-03-312019-04-24$11.46 billion$1.21$1.21-0.17%
2018-12-312019-01-30$13.66 billion$1.25$1.30-3.48%
2018-09-302018-10-18$13.12 billion$1.32$1.34-1.78%
2018-06-302018-07-18$13.45 billion$1.29$1.281.08%
2018-03-312018-04-19$12.69 billion$1.28$1.270.79%
2017-12-312018-01-24$12.92 billion$1.21$1.173.84%
2017-09-302017-10-24$12.41 billion$1.29$1.243.81%
2017-06-302017-07-18$12.24 billion$1.22$1.174.59%
2017-03-312017-04-25$11.54 billion$1.13$1.102.28%
2016-12-312017-01-25$12.32 billion$1.12$1.101.42%
2016-09-302016-10-25$12.13 billion$1.23$1.193.28%
2016-06-302016-07-19$12.47 billion$1.23$1.175.2%
2016-03-312016-04-21$11.6 billion$1.17$1.161.22%
2015-12-312016-01-27$12.52 billion$1.12$1.18-5.45%
2015-09-302015-10-27$12.27 billion$1.27$1.31-3.05%
2015-06-302015-07-21$12.69 billion$1.25$1.240.81%
2015-03-312015-04-23$11.96 billion$1.29$1.1017.27%
2014-12-312015-01-27$13.13 billion$1.21$1.210%
2014-09-302014-10-28$13.05 billion$1.37$1.296.2%
2014-06-302014-07-17$13.41 billion$1.34$1.40-4.29%
2014-03-312014-04-24$12.83 billion$1.28$1.33-3.76%
2013-12-312014-01-29$13.44 billion$1.19$1.26-5.56%
2013-09-302013-10-22$12.75 billion$1.25$1.31-4.58%
2013-06-302013-07-17$13.13 billion$1.28$1.29-0.78%
2013-03-312013-04-24$12.77 billion$1.32$1.283.13%
2012-12-312013-01-23$14.83 billion$1.27$1.196.72%
2012-09-302012-10-25$13.81 billion$1.34$1.36-1.47%
2012-06-302012-07-19$14.3 billion$1.38$1.296.98%
2012-03-312012-04-24$13.74 billion$1.27$1.32-3.79%
2011-12-312012-01-25$14.78 billion$1.23$1.202.5%
2011-09-302011-10-25$14.84 billion$1.45$1.51-3.97%
2011-06-302011-07-19$14.92 billion$1.48$1.405.71%
2011-03-312011-04-19$14.03 billion$1.41$1.317.63%
2010-12-312011-01-27$14.2 billion$1.14$1.25-8.8%
2010-09-302010-10-21$12.58 billion$1.27$1.205.83%
2010-06-302010-07-15$11.72 billion$1.20$1.136.19%
2010-03-312010-04-20$12.13 billion$1.44$1.2317.07%
2009-12-312010-01-26$12.93 billion$1.01$1.10-8.18%
2009-09-302009-10-22$11.09 billion$0.92$0.95-3.16%
2009-06-302009-07-16$10.55 billion$0.89$0.854.71%
2009-03-312009-04-23$9.71 billion$0.87$0.870%
2008-12-312009-01-28$10.08 billion$0.66$0.79-16.46%
2008-09-302008-10-20$10.75 billion$0.92$0.95-3.16%
2008-06-302008-07-17$10.73 billion$0.98$0.935.38%
2008-03-312008-04-21$9.91 billion$1.02$0.8914.61%
2007-12-312008-01-17$9.93 billion$0.40$0.73-45.21%
2007-09-302007-10-18$9.61 billion$0.68$0.76-10.53%
2007-06-302007-07-17$9.4 billion$0.83$0.786.41%
2007-03-312007-04-23$9.13 billion$0.92$0.849.52%
2006-12-312007-01-18$9.4 billion$0.70$0.78-10.26%
2006-09-302006-10-19$8.82 billion$0.79$0.763.95%
2006-06-302006-07-17$8.51 billion$0.73$0.79-7.59%
2006-03-312006-04-24$7.67 billion$0.83$0.7116.9%
2005-12-312006-01-19$7.45 billion$0.58$0.71-18.31%
2005-09-302005-10-18$8.42 billion$0.71$0.72-1.39%
2005-06-302005-07-14$7.8 billion$0.70$0.666.06%
2005-03-312005-04-21$7.34 billion$0.64
2004-12-312005-01-20$7.58 billion$0.56$0.60-6.67%
2004-09-302004-10-21$7.06 billion$0.63$0.588.62%
2004-06-302004-07-20$6.97 billion$0.63$0.596.78%
2004-03-312004-04-22$6.64 billion$0.52$0.53-1.89%
2003-12-312004-01-22$6.73 billion$0.55$0.533.77%
2003-09-302003-10-20$6.21 billion$0.52$0.520%
2003-06-302003-07-21$6.2 billion$0.52$0.511.96%
2003-03-312003-04-15$5.72 billion$0.43$0.46-6.52%
2002-12-312003-01-23$7 billion$0.46$0.51-9.86%
2002-09-302002-10-17$5.54 billion$0.47$0.447.11%
2002-06-302002-06-30$6.16 billion$0.50
2002-03-312002-03-31$4.74 billion$0.41
1997-06-301997-09-02$0.79$0.790%
1997-03-311997-04-22$0.52$0.4515.56%

Novartis AG (NVS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Novartis AG (NVS) Chart:

NVS chart by TradingView

Novartis AG (NVS) News:

Below you will find a list of latest news for Novartis AG (NVS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Novartis AG (NVS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1747.50CALL0 0176.45TRUE00
2024-05-17500CALL0 0244.22TRUE00
2024-05-17550CALL0 0143.21TRUE00
2024-05-17600CALL0 0123.4TRUE00
2024-05-17650CALL0 0111.13TRUE00
2024-05-17700CALL0 093.21TRUE00
2024-05-17750CALL0 064.5TRUE00
2024-05-17800CALL0 065.81TRUE00
2024-05-178513CALL0 270.41TRUE00
2024-05-1787.58.21CALL0 2055.63TRUE00
2024-05-17907.65CALL0 42030.75TRUE00
2024-05-1792.55.3CALL0 185642.62TRUE00
2024-05-17953.11CALL5 259821.81TRUE0.190.07
2024-05-1797.51.35CALL214 863419.66FALSE-0.2-0.13
2024-05-171000.45CALL22 157518.67FALSE-0.11-0.2
2024-05-171050.07CALL2 264322.42FALSE-0.03-0.3
2024-05-171100.05CALL0 220FALSE00
2024-05-171150.25CALL0 20FALSE00
2024-05-171200.09CALL0 20FALSE00
2024-05-171250CALL0 00FALSE00
2024-05-171300.05CALL0 5050FALSE00
2024-05-171350.05CALL0 2000FALSE00
2024-05-171400.27CALL0 10FALSE00
2024-05-171450CALL0 00FALSE00
2024-05-1747.50PUT0 00FALSE00
2024-05-17500PUT0 00FALSE00
2024-05-17550.05PUT0 500FALSE00
2024-05-17600.05PUT0 5000FALSE00
2024-05-17650.05PUT0 20FALSE00
2024-05-17700PUT0 00FALSE00
2024-05-17750.13PUT0 10FALSE00
2024-05-17800.08PUT0 230FALSE00
2024-05-17850.05PUT0 1170FALSE00
2024-05-1787.50.05PUT0 1540FALSE00
2024-05-17900.2PUT1 44528.45FALSE0.153
2024-05-1792.50.13PUT0 64318.96FALSE00
2024-05-17950.4PUT20 58615.8FALSE-0.06-0.13
2024-05-1797.51.2PUT34 17713.63TRUE-0.15-0.11
2024-05-171003.2PUT0 7415.73TRUE00
2024-05-1710510.3PUT0 021.1TRUE00
2024-05-171100PUT0 035.65TRUE00
2024-05-171150PUT0 094.46TRUE00
2024-05-171200PUT0 0108.53TRUE00
2024-05-171250PUT0 0119.38TRUE00
2024-05-171300PUT0 0131.3TRUE00
2024-05-171350PUT0 0144.68TRUE00
2024-05-171400PUT0 0155.23TRUE00
2024-05-171450PUT0 0165.19TRUE00
2024-06-21500CALL0 0115.18TRUE00
2024-06-21550CALL0 0104.2TRUE00
2024-06-21600CALL0 090.48TRUE00
2024-06-21650CALL0 080.36TRUE00
2024-06-21700CALL0 068.17TRUE00
2024-06-21750CALL0 056.62TRUE00
2024-06-21800CALL0 047.95TRUE00
2024-06-21850CALL0 031.64TRUE00
2024-06-2187.50CALL0 034.62TRUE00
2024-06-21908.25CALL0 7236.9TRUE00
2024-06-2192.57.05CALL0 9725.03TRUE00
2024-06-21953.65CALL0 325.95TRUE00
2024-06-2197.52.65CALL0 107820.28FALSE00
2024-06-211001.4CALL34 58719.25FALSE-0.07-0.05
2024-06-211050.38CALL3 19618.39FALSE-0.1-0.21
2024-06-211100.17CALL0 1220.71FALSE00
2024-06-211150CALL0 00FALSE00
2024-06-211200CALL0 00FALSE00
2024-06-211250CALL0 00FALSE00
2024-06-211300CALL0 00FALSE00
2024-06-211350CALL0 00FALSE00
2024-06-211400CALL0 00FALSE00
2024-06-21500PUT0 00FALSE00
2024-06-21550PUT0 00FALSE00
2024-06-21600PUT0 00FALSE00
2024-06-21650PUT0 00FALSE00
2024-06-21700PUT0 00FALSE00
2024-06-21750PUT0 00FALSE00
2024-06-21800.18PUT0 128.64FALSE00
2024-06-21850PUT0 022.33FALSE00
2024-06-2187.51PUT0 518.84FALSE00
2024-06-21900.35PUT0 11717.1FALSE00
2024-06-2192.50.6PUT0 2715.37FALSE00
2024-06-21951.25PUT0 10813.78FALSE00
2024-06-2197.52.2PUT0 39012.33TRUE00
2024-06-211003.5PUT0 10910.17TRUE00
2024-06-211059.5PUT0 6819.06TRUE00
2024-06-211100PUT0 029.03TRUE00
2024-06-211150PUT0 048.56TRUE00
2024-06-211200PUT0 056.17TRUE00
2024-06-211250PUT0 063.22TRUE00
2024-06-211300PUT0 069.81TRUE00
2024-06-211350PUT0 076TRUE00
2024-06-211400PUT0 081.83TRUE00
2024-07-1947.50CALL0 0109.62TRUE00
2024-07-19500CALL0 0104.04TRUE00
2024-07-19550CALL0 093.34TRUE00
2024-07-19600CALL0 082.24TRUE00
2024-07-19650CALL0 072.64TRUE00
2024-07-19700CALL0 063.34TRUE00
2024-07-19750CALL0 052.41TRUE00
2024-07-198022.6CALL0 043.13TRUE00
2024-07-198512.25CALL0 3036.58TRUE00
2024-07-1987.511.2CALL0 15338.32TRUE00
2024-07-19908.9CALL0 13533.7TRUE00
2024-07-1992.57.03CALL0 10629.38TRUE00
2024-07-19955CALL0 59924.21TRUE00
2024-07-1997.53.6CALL0 97222.73FALSE00
2024-07-191002.4CALL51 68021.53FALSE-0.1-0.04
2024-07-191050.9CALL10 118119.95FALSE-0.04-0.04
2024-07-191100.35CALL3 110320.27FALSE0.350
2024-07-191150.25CALL0 7420FALSE00
2024-07-191200.2CALL0 3880FALSE00
2024-07-191250.1CALL0 5520FALSE00
2024-07-191300.16CALL0 480FALSE00
2024-07-191350CALL0 00FALSE00
2024-07-191400CALL0 00FALSE00
2024-07-191450CALL0 00FALSE00
2024-07-191500.05CALL0 50FALSE00
2024-07-1947.50PUT0 00FALSE00
2024-07-19500.15PUT0 1240FALSE00
2024-07-19550PUT0 00FALSE00
2024-07-19600PUT0 00FALSE00
2024-07-19650.1PUT0 10FALSE00
2024-07-19700.3PUT0 10135.65FALSE00
2024-07-19750.25PUT0 1329.89FALSE00
2024-07-19800.35PUT0 1524.67FALSE00
2024-07-19850.41PUT0 18419.79FALSE00
2024-07-1987.50.48PUT0 23717.59FALSE00
2024-07-19900.68PUT0 47416.74FALSE00
2024-07-1992.51.05PUT10 69214.96FALSE0.050.05
2024-07-19951.79PUT0 86313.84FALSE00
2024-07-1997.52.65PUT10 71212.11TRUE0.20.08
2024-07-191004.16PUT0 6319.93TRUE00
2024-07-1910510.55PUT0 1820TRUE00
2024-07-1911010.7PUT0 330.7TRUE00
2024-07-1911511.7PUT0 137.36TRUE00
2024-07-1912015.02PUT0 043.5TRUE00
2024-07-1912527PUT0 049.24TRUE00
2024-07-1913023.61PUT0 054.61TRUE00
2024-07-1913528.52PUT0 059.68TRUE00
2024-07-1914033.4PUT0 064.47TRUE00
2024-07-1914547.3PUT0 069.02TRUE00
2024-07-1915043.7PUT0 073.34TRUE00
2024-10-1847.50CALL0 092.83TRUE00
2024-10-18500CALL0 090.24TRUE00
2024-10-18550CALL0 079.45TRUE00
2024-10-18600CALL0 071.5TRUE00
2024-10-18650CALL0 063.48TRUE00
2024-10-18700CALL0 056.88TRUE00
2024-10-18750CALL0 049.91TRUE00
2024-10-188020CALL0 1442.11TRUE00
2024-10-188515.3CALL0 141.25TRUE00
2024-10-1887.50CALL0 033.79TRUE00
2024-10-189010.8CALL0 4731.38TRUE00
2024-10-1892.58.1CALL0 3230.73TRUE00
2024-10-18958.01CALL0 1027.19TRUE00
2024-10-1897.56.15CALL0 16025.6FALSE00
2024-10-181004.6CALL5 20224.79FALSE4.60
2024-10-181052.8CALL0 38822.43FALSE00
2024-10-181101.5CALL0 38421.31FALSE00
2024-10-181151CALL0 51020.97FALSE00
2024-10-181200CALL0 021.25FALSE00
2024-10-181250.25CALL0 1122.31FALSE00
2024-10-181300CALL0 023.92FALSE00
2024-10-181350CALL0 025.09FALSE00
2024-10-181400CALL0 00FALSE00
2024-10-181450CALL0 00FALSE00
2024-10-181500CALL0 00FALSE00
2024-10-1847.50PUT0 00FALSE00
2024-10-18500PUT0 00FALSE00
2024-10-18550PUT0 00FALSE00
2024-10-18600PUT0 052.26FALSE00
2024-10-18650PUT0 039.95FALSE00
2024-10-18700PUT0 027.61FALSE00
2024-10-18750.45PUT0 3223.92FALSE00
2024-10-18800.48PUT0 11819.82FALSE00
2024-10-18850.8PUT1 220016.84FALSE0.80
2024-10-1887.51.1PUT0 9615.89FALSE00
2024-10-18901.5PUT33 41214.58FALSE1.50
2024-10-1892.52PUT0 36213.39FALSE00
2024-10-18952.8PUT16 15412.14FALSE2.80
2024-10-1897.53.5PUT0 28610.53TRUE00
2024-10-181004.3PUT0 459.4TRUE00
2024-10-181058PUT0 360TRUE00
2024-10-1811012.9PUT27 00TRUE12.90
2024-10-181150PUT0 010.92TRUE00
2024-10-181200PUT0 025.91TRUE00
2024-10-181250PUT0 030.15TRUE00
2024-10-181300PUT0 034.18TRUE00
2024-10-181350PUT0 037.99TRUE00
2024-10-181400PUT0 041.61TRUE00
2024-10-181450PUT0 045.04TRUE00
2024-10-181500PUT0 048.3TRUE00
2025-01-1737.564.93CALL1 00TRUE00
2025-01-17400CALL0 00TRUE00
2025-01-1742.50CALL0 00TRUE00
2025-01-17450CALL0 00TRUE00
2025-01-1747.559.4CALL0 088.48TRUE00
2025-01-175052.6CALL0 1785.3TRUE00
2025-01-17550CALL0 075.72TRUE00
2025-01-176042.5CALL0 069.27TRUE00
2025-01-176538.1CALL0 860.96TRUE00
2025-01-1767.50CALL0 00TRUE00
2025-01-177031.4CALL0 055.82TRUE00
2025-01-1772.517.45CALL2 70TRUE00
2025-01-177531CALL0 149.55TRUE00
2025-01-1777.530.7CALL7 70TRUE00
2025-01-178022.75CALL0 1043.53TRUE00
2025-01-1782.50CALL0 00TRUE00
2025-01-178518.96CALL0 237.98TRUE00
2025-01-1787.511.9CALL0 1932.07TRUE00
2025-01-179013.4CALL0 29932.98TRUE00
2025-01-1792.511.6CALL0 21131.9TRUE00
2025-01-179510.58CALL0 8830.2TRUE00
2025-01-1797.59.18CALL0 13728.7FALSE00
2025-01-171006.5CALL12 39427.33FALSE6.50
2025-01-171054.31CALL1 66025.45FALSE4.310
2025-01-171102.8CALL0 64523.76FALSE00
2025-01-171151.85CALL0 44023.01FALSE00
2025-01-171201CALL0 61022.49FALSE00
2025-01-171250.4CALL0 42523.56FALSE00
2025-01-171300.4CALL0 4750FALSE00
2025-01-171350.65CALL0 2300FALSE00
2025-01-171400.6CALL0 990FALSE00
2025-01-171450.25CALL0 770FALSE00
2025-01-171500.3CALL0 70FALSE00
2025-01-171550.28CALL0 10FALSE00
2025-01-171600.15CALL0 50FALSE00
2025-01-1737.50.2PUT1 2450FALSE00
2025-01-17400PUT0 00FALSE00
2025-01-1742.51PUT0 50FALSE00
2025-01-17450PUT0 00FALSE00
2025-01-1747.50.25PUT0 4900FALSE00
2025-01-17500.2PUT0 110FALSE00
2025-01-17550PUT0 00FALSE00
2025-01-17600.5PUT0 00FALSE00
2025-01-17650.75PUT0 5170FALSE00
2025-01-1767.50.9PUT1 320FALSE00
2025-01-17700.55PUT0 3140FALSE00
2025-01-1772.51.15PUT1 10FALSE00
2025-01-17750.6PUT41 19220.67FALSE0.60
2025-01-1777.51.2PUT2 2440FALSE00
2025-01-17801.11PUT0 18018.39FALSE00
2025-01-1782.52.35PUT1 2510FALSE00
2025-01-17851.9PUT0 66714.57FALSE00
2025-01-1787.52.65PUT0 11213.22FALSE00
2025-01-17902.1PUT0 31313.84FALSE00
2025-01-1792.52.95PUT2 91312.76FALSE2.950
2025-01-17953.48PUT0 13011.36FALSE00
2025-01-1797.54.56PUT0 2179.74TRUE00
2025-01-171005.52PUT0 2037.51TRUE00
2025-01-171058.8PUT0 3960TRUE00
2025-01-1711012.9PUT0 210TRUE00
2025-01-1711517.6PUT0 09.93TRUE00
2025-01-1712018PUT0 016.04TRUE00
2025-01-1712522.7PUT0 020.5TRUE00
2025-01-1713028.3PUT0 024.5TRUE00
2025-01-171350PUT0 028.16TRUE00
2025-01-171400PUT0 031.55TRUE00
2025-01-171450PUT0 034.7TRUE00
2025-01-171500PUT0 037.66TRUE00
2025-01-171550PUT0 040.46TRUE00
2025-01-171600PUT0 043.12TRUE00
2026-01-1647.50CALL0 071.18TRUE00
2026-01-165054.8CALL0 068.29TRUE00
2026-01-16550CALL0 062.78TRUE00
2026-01-166048CALL0 055.5TRUE00
2026-01-16650CALL0 051.83TRUE00
2026-01-167032.1CALL0 2247.84TRUE00
2026-01-16750CALL0 043.43TRUE00
2026-01-168027.5CALL0 241.9TRUE00
2026-01-168518.62CALL0 2037.79TRUE00
2026-01-1687.517.4CALL0 5337.27TRUE00
2026-01-169016.5CALL0 1137.07TRUE00
2026-01-1692.50CALL0 034.67TRUE00
2026-01-169512.3CALL0 1034.71TRUE00
2026-01-1697.517CALL0 632.8FALSE00
2026-01-1610011.5CALL0 6231FALSE00
2026-01-161058.71CALL2 18229.34FALSE8.710
2026-01-161106.8CALL0 41827.82FALSE00
2026-01-161155.41CALL0 16226.76FALSE00
2026-01-161204.3CALL0 18827.31FALSE00
2026-01-161253.4CALL0 22924.55FALSE00
2026-01-161303CALL0 525.91FALSE00
2026-01-161350CALL0 023.93FALSE00
2026-01-161401.85CALL0 2724.45FALSE00
2026-01-161451.53CALL0 3523.54FALSE00
2026-01-161500.8CALL0 624.03FALSE00
2026-01-161550CALL0 024.69FALSE00
2026-01-161600CALL0 00FALSE00
2026-01-1647.50.8PUT0 240FALSE00
2026-01-16500PUT0 00FALSE00
2026-01-16550.7PUT0 037.04FALSE00
2026-01-16600PUT0 023.21FALSE00
2026-01-16650.95PUT0 520.76FALSE00
2026-01-16701.55PUT0 13718.83FALSE00
2026-01-16751.8PUT0 8616.87FALSE00
2026-01-16802.55PUT46 74215.26FALSE2.550
2026-01-16853.2PUT0 45515.14FALSE00
2026-01-1687.53.9PUT0 37313.06FALSE00
2026-01-16904.7PUT0 12412.07FALSE00
2026-01-1692.55.6PUT0 7410.52FALSE00
2026-01-16956.4PUT0 17810.42FALSE00
2026-01-1697.59.3PUT0 119.35TRUE00
2026-01-161007.5PUT0 36.53TRUE00
2026-01-1610511.2PUT0 3186.85TRUE00
2026-01-1611011.83PUT0 00TRUE00
2026-01-1611518.07PUT0 20TRUE00
2026-01-161200PUT0 00TRUE00
2026-01-1612524.7PUT0 00TRUE00
2026-01-1613026PUT0 00TRUE00
2026-01-161350PUT0 00TRUE00
2026-01-161400PUT0 00TRUE00
2026-01-161450PUT0 012.75TRUE00
2026-01-161500PUT0 019.55TRUE00
2026-01-161550PUT0 021.52TRUE00
2026-01-161600PUT0 025.21TRUE00

Latest NVS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST14$82.55
Jun 13, 2022 7:59 PM EST8$82.53
Jun 13, 2022 7:59 PM EST200$82.54

Novartis AG (NVS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319026793/0000899243-19-026793-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924320017188/0000899243-20-017188-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2019-12-05SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000104746919006660/0001047469-19-006660-index.htm
2020-01-30F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000609/0001047469-20-000609-index.htm
2020-02-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000795/0001047469-20-000795-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000837/0001047469-20-000837-index.htm
2020-02-14POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000872/0001047469-20-000872-index.htm
2019-05-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919031228/0001104659-19-031228-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032999/0001104659-19-032999-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919066818/0001104659-19-066818-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919067074/0001104659-19-067074-index.htm
2019-12-19SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919074076/0001104659-19-074076-index.htm
2019-12-23SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919075309/0001104659-19-075309-index.htm
2020-01-06SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920001225/0001104659-20-001225-index.htm
2020-02-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920016892/0001104659-20-016892-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054421/0001104659-20-054421-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054428/0001104659-20-054428-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054430/0001104659-20-054430-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054435/0001104659-20-054435-index.htm
2020-06-01SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920068035/0001104659-20-068035-index.htm
2020-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920076964/0001104659-20-076964-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920082864/0001104659-20-082864-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920084106/0001104659-20-084106-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920095585/0001104659-20-095585-index.htm
2020-08-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920096920/0001104659-20-096920-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001715/0001171843-19-001715-index.htm
2019-03-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001911/0001171843-19-001911-index.htm
2019-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319002004/0001171843-19-002004-index.htm
2019-05-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003156/0001171843-19-003156-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003609/0001171843-19-003609-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003610/0001171843-19-003610-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003629/0001171843-19-003629-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003886/0001171843-19-003886-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004272/0001171843-19-004272-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004915/0001171843-19-004915-index.htm
2019-08-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005727/0001171843-19-005727-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005958/0001171843-19-005958-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006182/0001171843-19-006182-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006290/0001171843-19-006290-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006403/0001171843-19-006403-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006937/0001171843-19-006937-index.htm
2019-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007057/0001171843-19-007057-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007596/0001171843-19-007596-index.htm
2019-11-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007762/0001171843-19-007762-index.htm
2019-12-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007956/0001171843-19-007956-index.htm
2019-12-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319008118/0001171843-19-008118-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000083/0001171843-20-000083-index.htm
2020-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000619/0001171843-20-000619-index.htm
2020-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001368/0001171843-20-001368-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001424/0001171843-20-001424-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001840/0001171843-20-001840-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002076/0001171843-20-002076-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002077/0001171843-20-002077-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002294/0001171843-20-002294-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320003608/0001171843-20-003608-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004387/0001171843-20-004387-index.htm
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004563/0001171843-20-004563-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004689/0001171843-20-004689-index.htm
2020-08-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320005971/0001171843-20-005971-index.htm
2020-08-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006020/0001171843-20-006020-index.htm
2020-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006198/0001171843-20-006198-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006593/0001171843-20-006593-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320007068/0001171843-20-007068-index.htm
2019-04-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000028/0001370368-19-000028-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000049/0001370368-19-000049-index.htm
2019-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000062/0001370368-19-000062-index.htm
2020-01-2920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm
2020-01-29IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1114448/000137036820000005/0001370368-20-000005-index.htm
2020-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000007/0001370368-20-000007-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000061/0001370368-20-000061-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000069/0001370368-20-000069-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000086/0001370368-20-000086-index.htm

Novartis AG (NVS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novartis AG (NVS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 1008%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-30Bioventures Ltd NovartisInsiderBuy125,000.0017.002,125,000.001,181,258.00https://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-05-28Bioventures Ltd Novartis10% Share HolderBuy168,630.0014.002,360,820.001,769,641.00https://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell20,610.001.9039,159.002,079,394.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell106,540.001.85197,099.002,100,004.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-15Bioventures Ltd Novartis10% Share HolderSell43,800.001.9284,096.002,206,544.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-14Bioventures Ltd Novartis10% Share HolderSell13,800.001.8825,944.002,250,344.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-13Bioventures Ltd Novartis10% Share HolderSell132,738.002.12281,404.562,264,144.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2020-06-19Bioventures Ltd NovartisInsiderSell1,001,312.008.258,260,824.002,467,961.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-18Bioventures Ltd NovartisInsiderSell900.009.048,136.003,469,273.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-17Bioventures Ltd Novartis10% Share HolderSell4,622.009.2742,845.943,470,173.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-16Bioventures Ltd Novartis10% Share HolderSell8,600.009.3079,980.003,474,795.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-15Bioventures Ltd Novartis10% Share HolderSell6,164.009.0555,784.203,483,395.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-12Bioventures Ltd Novartis10% Share HolderSell1,500.009.1913,785.003,489,559.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-11Bioventures Ltd Novartis10% Share HolderSell7,200.009.2166,312.003,491,059.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-10Bioventures Ltd Novartis10% Share HolderSell8,532.009.4680,712.723,498,259.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-09Bioventures Ltd Novartis10% Share HolderSell7,000.009.3865,660.003,506,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-08Bioventures Ltd Novartis10% Share HolderSell5,659.009.6654,665.943,513,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-05Bioventures Ltd Novartis10% Share HolderSell8,652.009.6683,578.323,519,450.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-04Bioventures Ltd Novartis10% Share HolderSell4,088.009.5539,040.403,528,102.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-03Bioventures Ltd Novartis10% Share HolderSell5,208.009.7850,934.243,532,190.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-02Bioventures Ltd Novartis10% Share HolderSell5,669.009.6854,875.923,537,398.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2019-11-12Bioventures Ltd Novartis10% Share HolderBuy250,000.0012.003,000,000.003,543,067.00https://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2019-04-26Bioventures Ltd Novartis10% Share HolderSell138,704.001.03142,865.124,049,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-25Bioventures Ltd Novartis10% Share HolderSell563,096.001.03579,988.884,188,508.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-24Bioventures Ltd Novartis10% Share HolderSell16,403.001.0316,895.094,751,604.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-23Bioventures Ltd Novartis10% Share HolderSell27,554.001.0328,380.624,768,007.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-22Bioventures Ltd Novartis10% Share HolderSell7,100.000.976,887.004,795,561.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-15Bioventures Ltd Novartis10% Share HolderSell28,794.000.9928,506.064,802,661.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-12Bioventures Ltd Novartis10% Share HolderSell30,908.001.0432,144.324,831,455.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-11Bioventures Ltd Novartis10% Share HolderSell57,438.001.0862,033.044,862,363.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-10Bioventures Ltd Novartis10% Share HolderSell140,230.001.09152,850.704,919,801.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-09Bioventures Ltd Novartis10% Share HolderSell32,991.001.0133,320.915,060,031.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-08Bioventures Ltd Novartis10% Share HolderSell27,525.001.0228,075.505,093,022.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-05Bioventures Ltd Novartis10% Share HolderSell24,661.001.0225,154.225,120,547.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-04Bioventures Ltd Novartis10% Share HolderSell47,900.001.0148,379.005,145,208.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-03Bioventures Ltd Novartis10% Share HolderSell58,033.000.9655,711.685,193,108.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-02Bioventures Ltd Novartis10% Share HolderSell51,754.000.9750,201.385,251,141.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell116,909.000.95111,063.555,302,895.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell63,100.000.9157,421.005,419,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-28Bioventures Ltd Novartis10% Share HolderSell88,835.000.9483,504.905,482,904.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-27Bioventures Ltd Novartis10% Share HolderSell50,749.000.9950,241.515,571,739.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-26Bioventures Ltd Novartis10% Share HolderSell177,762.001.01179,539.625,622,488.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm